257 related articles for article (PubMed ID: 22460182)
21. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
[TBL] [Abstract][Full Text] [Related]
22. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
Gazzaruso C; Solerte SB; Pujia A; Coppola A; Vezzoli M; Salvucci F; Valenti C; Giustina A; Garzaniti A
J Am Coll Cardiol; 2008 May; 51(21):2040-4. PubMed ID: 18498958
[TBL] [Abstract][Full Text] [Related]
23. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study.
Wu IW; Hsu KH; Hsu HJ; Lee CC; Sun CY; Tsai CJ; Wu MS
Nephrol Dial Transplant; 2012 Mar; 27(3):1169-75. PubMed ID: 21891772
[TBL] [Abstract][Full Text] [Related]
24. Predicting outcomes after myocardial infarction by using the Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease study equation: results from the Korea Acute Myocardial Infarction Registry.
Choi JS; Kim CS; Bae EH; Ma SK; Ahn YK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Kim SW;
Nephrol Dial Transplant; 2012 Oct; 27(10):3868-74. PubMed ID: 22879394
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
[TBL] [Abstract][Full Text] [Related]
26. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
[TBL] [Abstract][Full Text] [Related]
27. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.
Sedlis SP; Jurkovitz CT; Hartigan PM; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; O'Rourke RA; Boden WE; Weintraub WS;
Am J Cardiol; 2009 Dec; 104(12):1647-53. PubMed ID: 19962469
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between estimated glomerular filtration rate level and clinical characteristics and outcome in patients with angiographic coronary artery disease and normal serum creatinine].
Li Q; Gao YC; He JQ; Jiang TY; Ren XJ; Chen F
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jul; 41(7):563-7. PubMed ID: 24284182
[TBL] [Abstract][Full Text] [Related]
29. Body mass index, coronary artery calcification, and kidney function decline in stage 3 to 5 chronic kidney disease patients.
Garland JS; Holden RM; Hopman WM; Gill SS; Nolan RL; Morton AR
J Ren Nutr; 2013 Jan; 23(1):4-11. PubMed ID: 22542819
[TBL] [Abstract][Full Text] [Related]
30. Endothelial function and cardiovascular events in chronic kidney disease.
Hirata Y; Sugiyama S; Yamamoto E; Matsuzawa Y; Akiyama E; Kusaka H; Fujisue K; Kurokawa H; Matsubara J; Sugamura K; Maeda H; Iwashita S; Jinnouchi H; Matsui K; Ogawa H
Int J Cardiol; 2014 May; 173(3):481-6. PubMed ID: 24703800
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
[TBL] [Abstract][Full Text] [Related]
32. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
[TBL] [Abstract][Full Text] [Related]
33. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
[TBL] [Abstract][Full Text] [Related]
34. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
[TBL] [Abstract][Full Text] [Related]
35. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
37. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome.
Batra G; Ghukasyan Lakic T; Lindbäck J; Held C; White HD; Stewart RAH; Koenig W; Cannon CP; Budaj A; Hagström E; Siegbahn A; Wallentin L;
JAMA Cardiol; 2021 Dec; 6(12):1440-1445. PubMed ID: 34431970
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease.
Bao YS; Na SP; Jia XB; Liu RC; Wang MA; Yu CY; Mu SH; Xie RJ
Curr Med Res Opin; 2012 Mar; 28(3):379-84. PubMed ID: 22335251
[TBL] [Abstract][Full Text] [Related]
40. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
Holle J; Querfeld U; Kirchner M; Anninos A; Okun J; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Duzova A; Anarat A; Shroff R; Bilginer Y; Caliskan S; Candan C; Harambat J; Özcakar ZB; Soylemezoglu O; Tschumi S; Habbig S; Yilmaz E; Balat A; Zurowska A; Cakar N; Kranz B; Ertan P; Melk A; Azukaitis K; Schaefer F
Pediatr Nephrol; 2019 Dec; 34(12):2571-2582. PubMed ID: 31428929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
